Insights on Discovery

  1. mTOR Pathway 3/24/2025

    Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

  2. VEGF Signaling Pathway 3/24/2025

    In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

  3. Neuroinflammation In Alzheimer's Disease Pathway 3/24/2025

    Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

  4. Alzheimer's Disease Pathway 3/24/2025

    Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

  5. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

  6. Multiplex Imaging 3/24/2025

    Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

  7. Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody 3/24/2025

    Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

  8. Minimize Off-Target Effects With Precision Genome Editing 3/20/2025

    On the path to successfully delivering a safe and efficacious gene editing therapy to patients, drug sponsors must leverage a robust arsenal of tools to mitigate off-target effects on the genome. Said tools include in silico prediction software, especially those that consider epigenetic features when predicting off-target effects.

  9. Navigating The Evolving Landscape Of Immunotherapy in Oncology 3/17/2025

    Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.

  10. Assessment Of Compound Toxicity Effects With High-Content Imaging 3/17/2025

    3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.